# Mirata BioPharma, LLC — Form D

Mirata BioPharma, LLC of NATICK, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-10. The offering totals $500K, of which $500K was reported sold. Industry: Other Technology.

## Offering

- Filed: 2018-05-10
- Form: D
- Accession: 0001738552-18-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Minimum investment: $50K
- Investors: 4
- Date of first sale: 2018-05-04
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-312052

## Issuer

- Name: Mirata BioPharma, LLC
- CIK: 0001738552
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 27 STRATHMORE RD, NATICK, MA, 01760
- Phone: 781-761-0123

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Keizo Koya | Director | Natick, MA |
| Keizo Koya | Executive Officer | Natick, MA |
| Keizo Koya | Promoter | Natick, MA |

## More

- [CIK 1738552 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1738552&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001738552-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.